Nice to meet you!

Welcome to the ILUMYA® (tildrakizumab-asmn) Virtual Learning Center.

Topics include:
  • 5-year safety and efficacy data
  • BMI and other metabolic syndrome risk factors
  • Overall safety data
  • Dosing*
  • Coverage and access information
*Go to ILUMYAPRO.com for biologic dosing burden through 5 years.
Let’s Get Started
Review EFFICACY